GlassScriptPhysician profile
Ahmet Bedestani
NPI 1134328800
$41,128.91
in general payments reported to CMS, 2019-2025
20 companies · $2,618 in 2025
The $2,618 reported for 2025 was more than what 95% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $16K · 2020: $20K · 2021: $519 · 2022: $372 · 2023: $1,152 · 2024: $675 · 2025: $2,618.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,428 · Food and Beverage: $2,017.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,427.91 |
| Food and Beverage | $2,016.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopersurgical, INC. | $35,001.24 | 2019-2022 | |
| Boston Scientific Corporation | $2,261.23 | 2022-2025 | Upsylon, Axonics, Bulkamid |
| Intuitive Surgical, INC. | $1,455.59 | 2019-2025 | |
| Medtronic USA, INC. | $790.39 | 2019-2020 | |
| Caldera Medical, INC | $320.06 | 2024 | Desara |
| Sumitomo Pharma America, INC. | $314.41 | 2023-2025 | Gemtesa |
| Biom'Up France Sas | $198.95 | 2021 | |
| Axonics, INC. | $192.62 | 2020-2024 | Bulkamid |
| Allotrope Medical, INC | $163.67 | 2022 | |
| Coloplast Corp | $88.35 | 2021-2024 | |
| Astellas Pharma US INC | $85.33 | 2020-2023 | Myrbetriq |
| Pfizer INC. | $67.38 | 2019-2023 | |
| Urovant Sciences INC | $49.10 | 2022 | |
| Allergan, INC. | $28.09 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $25.85 | 2023 | Exparel |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hollister Incorporated | $20.61 | 2022 | |
| Renovia INC | $18.14 | 2021 | |
| Merck Sharp & Dohme LLC | $17.78 | 2020 | |
| Mallinckrodt Hospital Products INC. | $17.03 | 2020 | |
| Duchesnay USA Incorporated | $13.09 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ahmet Bedestani listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.